| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |